Reversible vestibular dysfunction secondary to sotalol use

J Interv Card Electrophysiol. 2010 Jan;27(1):17-21. doi: 10.1007/s10840-009-9441-4. Epub 2009 Oct 21.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Arrhythmia Agents / adverse effects
  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Sotalol / adverse effects*
  • Sotalol / therapeutic use
  • Vestibular Diseases / chemically induced*
  • Vestibular Diseases / prevention & control*

Substances

  • Anti-Arrhythmia Agents
  • Sotalol